This draft guideline represents an historic step for the prevention of breast cancer - it is the first time drugs have ever been recommended for reducing breast cancer risk in the UK.This is exciting as, even though most women do not have a significant family history of the disease, it's crucial that those who do have an array of options to help them control their risk.
An update to this guideline is long overdue and we're especially pleased it has been extended to include both women who have had breast cancer, and men, for the first time.
Once finalised, this guideline will pose new challenges for the NHS as it will need to deliver on its recommendations, including a potentially large increase in genetic testing.
More top news
Hay fever sufferers are warned pollen levels will be very high.
Italy, under a new anti-migrant government, has refused to let aid groups dock in Italian ports,
Almost 4,000 England fans were thought to be in the Nizhny Novgorod Stadium.